Inactivation of HIV in blood (Q78493198)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

title

Inactivation of HIV in blood (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Asa Ohagen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

Veronica Gibaja

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

Saika Aytay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

Jeff Horrigan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

Douglas Lunderville

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

Aris Lazo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

1308-1317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

Trends in incidence of AIDS associated with transfusion of blood and blood products in Europe and the United States, 1985-93

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Transfusion medicine. First of two parts--blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Pathogen inactivation of labile blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

A universal virus inactivant for decontaminating blood and biopharmaceutical products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Reactions of ethyleneimine with guanosine and deoxyguanosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Ring-opened 7-methylguanine residues in DNA are a block to in vitro DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Inactivation and removal of blood-borne viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Complete nucleotide sequence of the AIDS virus, HTLV-III

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Human Immunodeficiency Virus Type-1 mRNA Splicing Pattern in Infected Persons Is Determined by the Proportion of Newly Infected Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

A quantitative assay for HIV DNA integration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Role of vif during packing of the core of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Infection of Macaca nemestrina by human immunodeficiency virus type-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Expression of HIV-1 integrase in E. coli: immunological analysis of the recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

The antigenic structure of the HIV gp120 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

New antiretroviral agents: looking beyond protease and reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Survival and Disinfectant Inactivation of the Human Immunodeficiency Virus: A Critical Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

Vertical-scanning mutagenesis of a critical tryptophan in the "minor groove binding track" of HIV-1 reverse transcriptase. Major groove DNA adducts identify specific protein interactions in the minor groove.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2002.00217.X

10.1046/J.1537-2995.2002.00217.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12423515 AND SRC:MED&resulttype=core&format=json

14 December 2019

1 reference